You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NRIX Exercise Disclosure
Ring Christine · SEC Form 4 · Filed Sep 2, 2026
Exercise
Calculated transaction value
$0
Ring Christine Chief Legal Officer
NRIX
Nurix Therapeutics
NRIX
Transaction date
Sep 2, 2026
Public filing date
Sep 2, 2026
Filing lag
Filed same day
NRIX daily price context
Close on/before transaction
$25.82
Sep 2, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (right to buy) on Common Stock
- Quantity / price
- 5,787 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001817199-26-000030
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$199.53K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nurix Therapeutics, Inc. NRIX | Sale | Sep 2, 2026 | $10.65K |
| Nurix Therapeutics, Inc. NRIX Current | Exercise | Sep 2, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Sep 2, 2026 | $50.46K |
| Nurix Therapeutics, Inc. NRIX | Sale | Sep 2, 2026 | $138.42K |